DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Beta Drugs Limited — Investor Presentation

NSE 1 hr ago·27 Jul 2026, 3:54 pm

Beta Drugs

Beta Drugs Limited has submitted its investor presentation to the stock exchange, a routine disclosure that provides an overview of the company's current business status and future outlook. This document typically outlines the firm's financial performance, strategic initiatives, and operational plans for the upcoming period.

For investors, this update is a key opportunity to gain clarity on management's perspective on the company's trajectory. It helps in assessing the firm's growth potential and understanding the roadmap for future expansion or operational efficiency.

Investors should focus on the management commentary within the presentation to gauge the company's confidence and future direction. Keeping an eye on the specific strategies outlined will be crucial for understanding the company's path forward.